Compare BioNTech SE - ADR (BNTX) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Twist Bioscience Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: BioNTech SE - ADR is far larger — about 3× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | TWST | |
|---|---|---|
Market Cap | $23.31B | $7.72B |
Sector | Health | Health |
52-Week High | $119.34 | $124.88 |
52-Week Low | $83.89 | $24.16 |
Enterprise Value | $6.60B | $7.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
